Disruption of p38MAPK signaling was achieved by expression of a kinase-inactive p38MAPK-AGF mutant (a dominant-negative p38, dn-p38) in breast cancer MDA-MB-231 cell line, established from a patient with metastatic triple-negative breast cancer (TNBC). Here, MAPK14 is linked to breast cancer.